1. Home
  2. CCS vs TSHA Comparison

CCS vs TSHA Comparison

Compare CCS & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Communities Inc.

CCS

Century Communities Inc.

HOLD

Current Price

$69.12

Market Cap

1.7B

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$6.88

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCS
TSHA
Founded
2000
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
CCS
TSHA
Price
$69.12
$6.88
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$64.80
$11.63
AVG Volume (30 Days)
334.7K
2.3M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
5.56
EPS
0.84
N/A
Revenue
$4,117,816,000.00
$9,773,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.84
$1,152.42
P/E Ratio
$74.74
N/A
Revenue Growth
N/A
17.28
52 Week Low
$47.28
$2.25
52 Week High
$76.00
$7.30

Technical Indicators

Market Signals
Indicator
CCS
TSHA
Relative Strength Index (RSI) 76.37 68.00
Support Level $55.64 $4.39
Resistance Level $70.86 $7.30
Average True Range (ATR) 2.58 0.40
MACD 1.06 0.15
Stochastic Oscillator 90.58 88.09

Price Performance

Historical Comparison
CCS
TSHA

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Share on Social Networks: